Biocon Marks GLP-1 Milestone With UK Liraglutide Launch
Indian Firm Introduces Rivals To Victoza And Saxenda
Biocon has announced the UK launch of its liraglutide generic rivals to Victoza and Saxenda, hailing a “significant milestone” for the firm’s GLP-1 business, which it expects to be a major growth driver in years to come.
